{"id":542,"date":"2026-08-27T18:00:00","date_gmt":"2026-08-27T18:00:00","guid":{"rendered":"https:\/\/nhdbio.com\/?p=542"},"modified":"2026-08-28T08:41:50","modified_gmt":"2026-08-28T08:41:50","slug":"hplc-area-purity-vs-assay-mass-fraction-peptide","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/fr\/hplc-area-purity-vs-assay-mass-fraction-peptide\/","title":{"rendered":"Puret\u00e9 de la zone HPLC par rapport au test\u00a0: pourquoi un pic 99% ne contient pas de peptide 99%"},"content":{"rendered":"<p>\u00ab\u00a099% pure by HPLC\u00a0\u00bb est l'une des expressions les plus mal comprises dans la documentation sur les peptides. Dans le contexte habituel de normalisation de zone, cela signifie que le pic principal a contribu\u00e9 environ \u00e0 99% \u00e0 la r\u00e9ponse int\u00e9gr\u00e9e du d\u00e9tecteur parmi les pics compt\u00e9s par cette m\u00e9thode chromatographique. Cela ne signifie pas que le 99% de la masse de poudre est le peptide cible.<\/p>\n<p>Cette distinction suit une r\u00e8gle analytique de base refl\u00e9t\u00e9e dans <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q2r2-validation-analytical-procedures\" rel=\"noopener\">ICHQ2(R2)<\/a> et <a href=\"https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q14_Guideline_2023_1116.pdf\" rel=\"noopener\">ICH Q14<\/a>: une proc\u00e9dure doit \u00eatre comprise par rapport \u00e0 sa destination. Un profil d'impuret\u00e9s chromatographique et un test quantitatif peuvent utiliser un \u00e9quipement similaire tout en r\u00e9pondant \u00e0 des questions diff\u00e9rentes.<\/p>\n<h2>Ce que mesure r\u00e9ellement le pourcentage de surface HPLC<\/h2>\n<p>Dans un chromatogramme UV typique, le logiciel int\u00e8gre les pics s\u00e9lectionn\u00e9s. La superficie du pic principal est divis\u00e9e par la superficie totale incluse. Ce rapport d\u00e9pend de la longueur d'onde du d\u00e9tecteur, de la pr\u00e9paration de l'\u00e9chantillon, de la colonne, du gradient, des param\u00e8tres d'int\u00e9gration et des compos\u00e9s qui produisent une r\u00e9ponse. Un composant qui n'absorbe pas \u00e0 la longueur d'onde s\u00e9lectionn\u00e9e peut contribuer \u00e0 la masse sans appara\u00eetre comme un pic comparable.<\/p>\n<p>L'eau, de nombreux sels inorganiques et certains apports de contre-ions en sont des exemples \u00e9vidents. M\u00eame parmi les compos\u00e9s actifs UV, une masse \u00e9gale ne garantit pas une r\u00e9ponse \u00e9gale du d\u00e9tecteur. La co-\u00e9lution peut combiner les composants en un seul pic\u00a0; une impuret\u00e9 inf\u00e9rieure au seuil de d\u00e9claration peut \u00eatre exclue\u00a0; un front de solvants tr\u00e8s pr\u00e9coce peut \u00eatre ignor\u00e9. Par cons\u00e9quent, la normalisation de zone est un profil chromatographique utile et non un test gravim\u00e9trique universel.<\/p>\n<h2>La puret\u00e9, le dosage et le contenu sont des quantit\u00e9s distinctes<\/h2>\n<div class=\"pim-data-table\">\n<table>\n<thead>\n<tr>\n<th>Valeur d\u00e9clar\u00e9e<\/th>\n<th>R\u00e9ponse \u00e0 la question<\/th>\n<th>Ce qu'il n'\u00e9tablit pas seul<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>% de la zone du pic principal HPLC<\/td>\n<td>Quelle est la dominante du pic principal d\u00e9tect\u00e9 avec cette m\u00e9thode\u00a0?<\/td>\n<td>Fraction massique cible, identit\u00e9, quantit\u00e9 d'eau ou de contre-ion<\/td>\n<\/tr>\n<tr>\n<td>Essai<\/td>\n<td>Quelle quantit\u00e9 d\u2019analyte est pr\u00e9sente par rapport \u00e0 une norme appropri\u00e9e et \u00e0 une base d\u00e9clar\u00e9e\u00a0?<\/td>\n<td>Chaque identit\u00e9 d'impuret\u00e9 ou s\u00e9quence compl\u00e8te<\/td>\n<\/tr>\n<tr>\n<td>Eau\/teneur volatile<\/td>\n<td>Quelle quantit\u00e9 de masse non-analyte sp\u00e9cifi\u00e9e est pr\u00e9sente\u00a0?<\/td>\n<td>Puret\u00e9 chromatographique ou identit\u00e9 peptidique<\/td>\n<\/tr>\n<tr>\n<td>R\u00e9sultat du contre-ion<\/td>\n<td>Quelle quantit\u00e9 d\u2019ac\u00e9tate, de TFA ou d\u2019autres ions a \u00e9t\u00e9 mesur\u00e9e\u00a0?<\/td>\n<td>Contenu cible total sauf combinaison avec le reste de la composition<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2>Un calcul hypoth\u00e9tique transparent<\/h2>\n<p>Supposons \u2013 et non comme un r\u00e9sultat r\u00e9el \u2013 qu'une poudre soit signal\u00e9e comme zone de pic principal 99.2% HPLC. Des mesures s\u00e9par\u00e9es trouvent l'eau 6.0% et le contre-ion 8.0% en masse. Il serait erron\u00e9 d\u2019\u00e9tiqueter la poudre \u00ab teneur en peptide 99.2% \u00bb. Avant m\u00eame de prendre en compte les autres r\u00e9sidus, la masse non peptidique modifie d\u00e9j\u00e0 le contenu net possible.<\/p>\n<p>Le calcul exact d\u00e9pend de la mani\u00e8re dont le test est d\u00e9fini\u00a0: base telle quelle, base anhydre, base corrig\u00e9e par contre-ions, \u00e9quivalent en peptide libre ou autre sp\u00e9cification. Le certificat doit nommer cette base. Autrement, deux nombres math\u00e9matiquement corrects peuvent para\u00eetre contradictoires lorsqu\u2019ils sont simplement normalis\u00e9s diff\u00e9remment.<\/p>\n<h2>Pourquoi les normes de r\u00e9f\u00e9rence et les facteurs de r\u00e9ponse sont importants<\/h2>\n<p>Un test quantitatif n\u00e9cessite une r\u00e9f\u00e9rence appropri\u00e9e et une relation contr\u00f4l\u00e9e entre le signal et la quantit\u00e9. L'identit\u00e9 ou la puret\u00e9 de la r\u00e9f\u00e9rence, la pr\u00e9cision de la pr\u00e9paration, le mod\u00e8le d'\u00e9talonnage et les effets de matrice contribuent \u00e0 l'incertitude. Les caract\u00e9ristiques de validation pertinentes pour la m\u00e9thode peuvent inclure la sp\u00e9cificit\u00e9, l'exactitude, la pr\u00e9cision, la port\u00e9e et la robustesse. L\u2019inscription \u00ab\u00a0HPLC\u00a0\u00bb ne montre pas en soi que ces caract\u00e9ristiques ont \u00e9t\u00e9 \u00e9tablies pour une all\u00e9gation de contenu quantitatif.<\/p>\n<h2>Questions \u00e0 poser lorsque le titre dit 99%<\/h2>\n<ol>\n<li>99% est-il un r\u00e9sultat de zone de pic principal, un test calibr\u00e9 ou une limite de sp\u00e9cification\u00a0?<\/li>\n<li>Quels d\u00e9tecteurs, longueurs d'onde et r\u00e8gles d'int\u00e9gration ont \u00e9t\u00e9 utilis\u00e9s\u00a0?<\/li>\n<li>Les impuret\u00e9s li\u00e9es aux peptides \u00e9lu\u00e9es \u00e9troitement ont-elles \u00e9t\u00e9 r\u00e9solues de mani\u00e8re ad\u00e9quate\u00a0?<\/li>\n<li>Le r\u00e9sultat est-il rapport\u00e9 tel quel ou corrig\u00e9 pour l\u2019eau et les contre-ions\u00a0?<\/li>\n<li>Quelle norme de r\u00e9f\u00e9rence et quelle formule de calcul prennent en charge le test\u00a0?<\/li>\n<li>Les r\u00e9sultats concernant l'eau, les contre-ions, les solvants r\u00e9siduels et les r\u00e9sidus inorganiques compl\u00e8tent-ils le tableau du bilan massique\u00a0?<\/li>\n<\/ol>\n<h2>Comment r\u00e9diger la r\u00e9clamation avec pr\u00e9cision<\/h2>\n<p>Si la preuve disponible est uniquement un chromatogramme, la formulation d\u00e9fendable est \u00ab\u00a0zone du pic principal selon la m\u00e9thode HPLC indiqu\u00e9e\u00a0\u00bb, accompagn\u00e9e de la m\u00e9thode, du lot et du r\u00e9sultat. La \u00ab teneur en peptides \u00bb doit \u00eatre r\u00e9serv\u00e9e \u00e0 un r\u00e9sultat quantitatif dont la base est pr\u00e9cis\u00e9e. La \u00ab puret\u00e9 \u00bb doit \u00eatre qualifi\u00e9e afin que les lecteurs sachent s'il s'agit d'une mesure chromatographique, chimique ou d'une autre mesure d\u00e9finie.<\/p>\n<p>Ce langage pr\u00e9cis n\u2019est pas du p\u00e9dantisme. Cela \u00e9vite qu'on demande \u00e0 une m\u00e9thode de prouver un attribut pour lequel elle n'a jamais \u00e9t\u00e9 con\u00e7ue, et cela rend diff\u00e9rents fournisseurs ou lots comparables de mani\u00e8re significative.<\/p>","protected":false},"excerpt":{"rendered":"<p>Le pourcentage de surface HPLC, le dosage et la teneur nette en peptide r\u00e9pondent \u00e0 diff\u00e9rentes questions. Voici comment la r\u00e9ponse du d\u00e9tecteur, l'eau et les contre-ions modifient l'interpr\u00e9tation.<\/p>","protected":false},"author":1,"featured_media":648,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"","pim_article_type":"Quality documentation guide","pim_evidence_level":"ICH Q2(R2)\/Q14 analytical principles and FDA synthetic-peptide guidance; no lot-specific result","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"The numerical examples are transparent calculations, not test results for a catalog material. Only a validated lot-specific method and record can establish actual content.","pim_review_status":"reviewed","pim_review_reason":"Primary regulatory guidance and peer-reviewed analytical sources with explicit lot-evidence boundaries.","pim_creation_method":"The editorial workflow starts with linked regulatory guidance and peer-reviewed analytical-method records; extracts scope, definitions, required fields and limitations; and separates general method principles from product- and lot-specific claims. AI-assisted drafting was used to structure the first version. Claims, examples and boundaries were checked against the linked records in the site editorial workflow. This is not independent peer review or evidence that any catalog lot has passed the tests described.","pim_sources":"[{\"title\":\"ICH Q2(R2): Validation of Analytical Procedures\",\"url\":\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q2r2-validation-analytical-procedures\",\"note\":\"Defines validation characteristics and distinguishes quantitative analytical purposes.\"},{\"title\":\"ICH Q14: Analytical Procedure Development\",\"url\":\"https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q14_Guideline_2023_1116.pdf\",\"note\":\"Explains method purpose, performance characteristics and scientifically sound procedure development.\"},{\"title\":\"FDA: Analytical Procedures and Methods Validation for Drugs and Biologics\",\"url\":\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/analytical-procedures-and-methods-validation-drugs-and-biologics\",\"note\":\"Official guidance on analytical method submission and validation expectations.\"},{\"title\":\"FDA: ANDAs for Certain Highly Purified Synthetic Peptide Drug Products\",\"url\":\"https:\/\/www.fda.gov\/media\/107622\/download\",\"note\":\"Discusses peptide-related impurities and why robust analytical characterization matters.\"}]","footnotes":""},"categories":[21],"tags":[],"class_list":["post-542","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-quality-documentation-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HPLC Area Purity vs Assay: The 99% Peptide Problem<\/title>\n<meta name=\"description\" content=\"Understand why 99% HPLC area purity is not automatically 99% peptide by mass, and which assay, water and counterion data are needed for net content.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/fr\/hplc-area-purity-vs-assay-mass-fraction-peptide\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HPLC Area Purity vs Assay: Why a 99% Peak Is Not 99% Peptide Content\" \/>\n<meta property=\"og:description\" content=\"Understand why 99% HPLC area purity is not automatically 99% peptide by mass, and which assay, water and counterion data are needed for net content.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/fr\/hplc-area-purity-vs-assay-mass-fraction-peptide\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-27T18:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T08:41:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/hplc-area-purity-vs-assay-mass-fraction-peptide-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"HPLC Area Purity vs Assay: Why a 99% Peak Is Not 99% Peptide Content\",\"datePublished\":\"2026-08-27T18:00:00+00:00\",\"dateModified\":\"2026-08-28T08:41:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/\"},\"wordCount\":645,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/hplc-area-purity-vs-assay-mass-fraction-peptide-featured-v2.webp\",\"articleSection\":[\"Quality &amp; Documentation\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/\",\"name\":\"HPLC Area Purity vs Assay: The 99% Peptide Problem\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/hplc-area-purity-vs-assay-mass-fraction-peptide-featured-v2.webp\",\"datePublished\":\"2026-08-27T18:00:00+00:00\",\"dateModified\":\"2026-08-28T08:41:50+00:00\",\"description\":\"Understand why 99% HPLC area purity is not automatically 99% peptide by mass, and which assay, water and counterion data are needed for net content.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/hplc-area-purity-vs-assay-mass-fraction-peptide-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/hplc-area-purity-vs-assay-mass-fraction-peptide-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hplc-area-purity-vs-assay-mass-fraction-peptide\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HPLC Area Purity vs Assay: Why a 99% Peak Is Not 99% Peptide Content\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/fr\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Puret\u00e9 de la zone HPLC vs dosage\u00a0: le probl\u00e8me du peptide 99%","description":"Comprenez pourquoi la puret\u00e9 de la zone 99% HPLC n'est pas automatiquement le peptide 99% en masse, et quelles donn\u00e9es de dosage, d'eau et de contre-ion sont n\u00e9cessaires pour le contenu net.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/fr\/hplc-area-purity-vs-assay-mass-fraction-peptide\/","og_locale":"fr_FR","og_type":"article","og_title":"HPLC Area Purity vs Assay: Why a 99% Peak Is Not 99% Peptide Content","og_description":"Understand why 99% HPLC area purity is not automatically 99% peptide by mass, and which assay, water and counterion data are needed for net content.","og_url":"https:\/\/nhdbio.com\/fr\/hplc-area-purity-vs-assay-mass-fraction-peptide\/","og_site_name":"NHD","article_published_time":"2026-08-27T18:00:00+00:00","article_modified_time":"2026-08-28T08:41:50+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/hplc-area-purity-vs-assay-mass-fraction-peptide-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u00c9crit par":"NHD Technical Team","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"HPLC Area Purity vs Assay: Why a 99% Peak Is Not 99% Peptide Content","datePublished":"2026-08-27T18:00:00+00:00","dateModified":"2026-08-28T08:41:50+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/"},"wordCount":645,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/hplc-area-purity-vs-assay-mass-fraction-peptide-featured-v2.webp","articleSection":["Quality &amp; Documentation"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/","url":"https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/","name":"Puret\u00e9 de la zone HPLC vs dosage\u00a0: le probl\u00e8me du peptide 99%","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/hplc-area-purity-vs-assay-mass-fraction-peptide-featured-v2.webp","datePublished":"2026-08-27T18:00:00+00:00","dateModified":"2026-08-28T08:41:50+00:00","description":"Comprenez pourquoi la puret\u00e9 de la zone 99% HPLC n'est pas automatiquement le peptide 99% en masse, et quelles donn\u00e9es de dosage, d'eau et de contre-ion sont n\u00e9cessaires pour le contenu net.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/hplc-area-purity-vs-assay-mass-fraction-peptide-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/hplc-area-purity-vs-assay-mass-fraction-peptide-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/hplc-area-purity-vs-assay-mass-fraction-peptide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"HPLC Area Purity vs Assay: Why a 99% Peak Is Not 99% Peptide Content"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mati\u00e8res premi\u00e8res peptidiques et synth\u00e8se sur mesure","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"\u00c9quipe technique NHD","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"L'\u00e9quipe technique NHD maintient la documentation du catalogue d'utilisation de la recherche et les r\u00e9sum\u00e9s des preuves. Les articles examin\u00e9s renvoient \u00e0 des articles \u00e9valu\u00e9s par des pairs, \u00e0 des registres d'essais et \u00e0 des dossiers r\u00e9glementaires, conservent les r\u00e9sultats nuls et les limites des \u00e9tudes, et distinguent les interventions publi\u00e9es des documents du catalogue. Le dessin assist\u00e9 par AI peut \u00eatre utilis\u00e9 pour la structure\u00a0; les liens vers les sources et les limites des preuves restent visibles. Ce travail ne constitue pas un examen ind\u00e9pendant par des pairs ni un avis m\u00e9dical.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/fr\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/comments?post=542"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/542\/revisions"}],"predecessor-version":[{"id":548,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/542\/revisions\/548"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media\/648"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media?parent=542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/categories?post=542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/tags?post=542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}